Physician

Magdalena Dorota Lewandowska, M.D.

According to 2025 Medicare claims, Magdalena Lewandowska, M.D. (NPI: 1699907600) practices internal medicine in the Indianapolis-Carmel-Greenwood, IN market, with the plurality of this provider's patient population coming from Marion, IN. This provider's primary affiliated billing organization is INDIANA HEMOPHILIA & THROMBOSIS CENTER, INC. (NPI: 1659364800; TIN: 352047838) and primary practice location at 46260-1920.

Lewandowska's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 114 traditional Medicare patients, billed 1,053,549 HCPCS/CPT codes, and received $3,481,868 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 360 prescription claims across 80 beneficiaries totaling $248,529 in drug costs, led by Calquence (Acalabrutinib Maleate). Open Payments data shows 8 records totaling $14,966. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $465,727 and ending at $3,481,868. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $32,493 to $248,529. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	94	4,089	$465,727
2017	119	4,344	$756,463
2018	159	12,504	$1,485,529
2019	80	5,639	$1,058,386
2020	100	11,050	$744,367
2021	95	9,970	$1,506,645
2022	137	80,470	$7,444,798
2023	144	387,081	$1,051,068
2024	114	1,053,549	$3,481,868

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	23	88	$32,493
2016	19	52	$3,618
2017	27	83	$23,103
2018	56	204	$46,729
2019	41	157	$80,212
2020	56	237	$127,525
2021	58	219	$138,298
2022	73	328	$358,370
2023	78	336	$228,639
2024	80	360	$248,529

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	45	57	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	13	14	$58
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	16	20	$40
96366	Infusion into a vein for therapy, prevention, or diagnosis, each additional hour	12	23	$14
36415	Insertion of needle into vein for collection of blood sample	62	86	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	12	360	$106,992
Eliquis	Apixaban	78	4,030	$77,960
Xarelto	Rivaroxaban	24	1,500	$26,624
Celecoxib	Celecoxib	48	1,635	$5,951
Tranexamic Acid	Tranexamic Acid	26	204	$2,030

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$14,966	F. Hoffmann-La Roche AG
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Magdalena Dorota Lewandowska, M.D.?

Tedicare shows public-source Medicare data for Magdalena Dorota Lewandowska, M.D. (NPI 1699907600), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Magdalena Dorota Lewandowska, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Magdalena Dorota Lewandowska, M.D.?

Magdalena Dorota Lewandowska, M.D. is linked to INDIANA HEMOPHILIA & THROMBOSIS CENTER, INC. (billing NPI 1659364800) in the available physician profile data.

Does Magdalena Dorota Lewandowska, M.D. have Open Payments data?

Magdalena Dorota Lewandowska, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.